Accent Microcell Limited — Investor Meet, 20-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Accent Microcell has announced a board meeting to consider the financial results for the quarter and half-year. The company reported ₹265 crore revenue with 8% growth, 12% EBITDA increase, and 10% PAT growth for FY25. Units 1 and 2 ran near full capacity. Unit 3, starting by Sept-Oct 2025, will add 2,400 MT of premium excipient products, targeting ₹70 crore revenue in H2 FY26 and ₹150 crore peak in year one. Phase 2 (12,000 MT MCC) is planned for mid-2026 with ₹220–₹275 crore peak revenue. Export revenue stands at 53.5%, expected to rise post-expansion. Management is confident on margin improvement and strong demand for doubling capacity by FY28-29.